Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 3 composition records across product categories including Personal care.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of LACTOSE MONOHYDRATE in our catalog (epa_cpdat).
Products
3
Brands
1
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Canonical allergen markers detected on this ingredient. Each row is derived from the ingredient’s name or synonyms matching a known allergen class — useful when scanning a label for a specific allergy context.
Source: chemindex_name_match
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 3 composition records across product categories including Personal care.
US
FDA
Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 43 mg
US
FDA
Route: INTRACAVERNOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 174 mg
US
FDA
Route: INTRACAVITARY; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 47.5 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 150 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 214 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 150 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 900 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 750 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: 9.5 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 690 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 3990 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED; Maximum daily exposure: 300 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Maximum daily exposure: 265 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 2087 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 5364 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 8946 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Potency: 1691.8 mg/120ml
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: NA
US
FDA
Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 640 mg
US
FDA
Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 50 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: NA
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4384 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1412 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 1301 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 2313 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 2575 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 968 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 520 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 2794 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 366 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Maximum daily exposure: 25 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 98 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 214 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 107 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 505 mg
US
FDA
Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 586 mg
US
FDA
Route: VAGINAL; Dosage form: INSERT; Maximum daily exposure: 2282 mg